India has authorized emergency use of another Indian-made COVID-19 vaccine, after its producer said it prevented symptomatic infections in two-thirds of recipients.
New Delhi, August 23 (RHC)-- India has authorized emergency use of another Indian-made COVID-19 vaccine, after its producer said it prevented symptomatic infections in two-thirds of recipients. Regulators approved ZyCoV-D even though there’s no publicly available data on its performance in advanced clinical trials.
Meanwhile, in Taiwan, President Tsai Ing-wen has publicly received a shot of the home-grown Medigen vaccine. Regulators approved the two-dose vaccine last July — though a late-stage clinical trial remains ongoing.
